
Targeted salinomycin delivery with EGFR and CD133 aptamers based dual-ligand lipid-polymer nanoparticles to both osteosarcoma cells and cancer stem cells
Keywords: Osteosarcoma; Cancer stem cells; CD133; EGFR; Dual targeting; ANOVA; one-way analysis of variance; Ap-SAL-NP; salinomycin (sali)-entrapped nanoparticles labeled with CD133 aptamers; bFGF; basic fibroblast growth factor; cDNA; complementary DNA; CESP; Sali